Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

523.26
-16.8000-3.11%
Post-market: 525.622.36+0.45%17:09 EDT
Volume:259.41K
Turnover:135.02M
Market Cap:12.06B
PE:-36.81
High:539.71
Open:539.25
Low:513.36
Close:540.06
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:1.23
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:23.04
PE(LYR):-40.72

Loading ...

Madrigal Pharmaceuticals Q1 EPS USD 3.25

THOMSON REUTERS
·
May 06

Madrigal Pharmaceuticals Q1 Operating Expenses USD 404.06 Million

THOMSON REUTERS
·
May 06

Madrigal Pharmaceuticals Q1 Net Income USD -94.391 Million

THOMSON REUTERS
·
May 06

Madrigal Pharmaceuticals Inc: Ervogastat/Resmetirom Drug-Drug Interaction Study on Track to Initiate in 4Q26

THOMSON REUTERS
·
May 06

Top News Today: Stocks Rise, Oil Falls, as War Restart Fears Subside

Dow Jones
·
May 06

Madrigal Pharmaceuticals Inc - Announces Exclusive Global License for Aro-Pnpla3 From Arrowhead

THOMSON REUTERS
·
May 05

Arrowhead licenses ARO-PNPLA3 MASH drug to Madrigal for USD 25 million upfront

Reuters
·
May 05

Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline

GlobeNewswire
·
May 05

Is It Time To Reassess Madrigal Pharmaceuticals (MDGL) After Its Strong Five Year Share Price Gain

Simply Wall St.
·
May 03

Analysts Conflicted on These Healthcare Names: Teladoc (TDOC), Madrigal Pharmaceuticals (MDGL) and Pulmonx (LUNG)

TIPRANKS
·
Apr 30

Earning Preview: Madrigal Pharmaceuticals this quarter’s revenue is expected to increase by 160.32%, and institutional views are bullish

Earnings Agent
·
Apr 29

Madrigal Pharmaceuticals Reclassifies Board Ahead of 2026 Meeting

TIPRANKS
·
Apr 29

Madrigal reclassifies directors Baker, Brennan to Class I board seats

Reuters
·
Apr 29

Madrigal Pharmaceuticals announces annual shareholder meeting webcast

Reuters
·
Apr 29

Ritu Baral Reaffirms Buy on Madrigal Pharmaceuticals Following Updated Financial Model and Sustained Long-Term Upside Outlook

TIPRANKS
·
Apr 23

Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026

GlobeNewswire
·
Apr 22

Madrigal grants 5,758 inducement RSUs to 12 new employees under 2025 plan

Reuters
·
Apr 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 22

Is It Too Late To Consider Madrigal Pharmaceuticals (MDGL) After Recent Share Price Surge?

Simply Wall St.
·
Apr 10

Madrigal grants 8,079 inducement RSUs to 20 new employees under 2025 plan

Reuters
·
Apr 08